Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications. - Wikidata - wikimedia - TriplyDB

Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications.

Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications.

http://www.wikidata.org/entity/Q37821136

about

Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac death Markov models of use-dependence and reverse use-dependence during the mouse cardiac action potential A compartmentalized mathematical model of the β1-adrenergic signaling system in mouse ventricular myocytes Improved functional expression of human cardiac kv1.5 channels and trafficking-defective mutants by low temperature treatment The mechanisms of calcium cycling and action potential dynamics in cardiac alternans Novel pharmacological targets for the rhythm control management of atrial fibrillation.Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone.A Regional Reduction in Ito and IKACh in the Murine Posterior Left Atrial Myocardium Is Associated with Action Potential Prolongation and Increased Ectopic Activity.Atrial-selective prolongation of refractory period with AVE0118 is due principally to inhibition of sodium channel activity.PKC and AMPK regulation of Kv1.5 potassium channels L-Type Calcium Channel Inhibition Contributes to the Proarrhythmic Effects of Aconitine in Human Cardiomyocytes.Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation.Effects of IKur blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation Atrial remodeling in atrial fibrillation and association between microRNA network and atrial fibrillation.Novel molecular targets for atrial fibrillation therapy.Potassium channels in Drosophila: historical breakthroughs, significance, and perspectives.Atrial selectivity of antiarrhythmic drugs.Identifying potential functional impact of mutations and polymorphisms: linking heart failure, increased risk of arrhythmias and sudden cardiac death The role of the cytosolic HSP70 chaperone system in diseases caused by misfolding and aberrant trafficking of ion channels Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia.The positive frequency-dependent electrophysiological effects of the IKur inhibitor XEN-D0103 are desirable for the treatment of atrial fibrillation.Alternans in atria: Mechanisms and clinical relevance.High fat diet induced alterations of atrial electrical activities in mice.Inhibitory effects of cholinesterase inhibitor donepezil on the Kv1.5 potassium channel.Putative binding sites for arachidonic acid on the human cardiac Kv 1.5 channel.Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation.Inhibition of a TREK-like K+ channel current by noradrenaline requires both β1- and β2-adrenoceptors in rat atrial myocytes.Revealing kinetics and state-dependent binding properties of IKur-targeting drugs that maximize atrial fibrillation selectivity.PKC inhibition results in a Kv 1.5 + Kv β1.3 pharmacology closer to Kv 1.5 channels.Multi-channel blockers for treatment of atrial fibrillation: an effective strategy?Pergolide block of the cloned Kv1.5 potassium channels.Multiple mechanisms mediating carbon monoxide inhibition of the voltage-gated K+ channel Kv1.5.Synergistic Anti-arrhythmic Effects in Human Atria with Combined Use of Sodium Blockers and Acacetin.Taurine Prevents the Electrical Remodeling in Ach-CaCl2 Induced Atrial Fibrillation in Rats.Inhibition of Kv4.3 potassium channels by trazodone.Isoenzyme-specific regulation of cardiac Kv1.5/Kvβ1.2 ion channel complex by protein kinase C: central role of PKCβII.Regulation of human cardiac Kv1.5 channels by extracellular acidification.Enhancement of 5-HT2A receptor function and blockade of Kv1.5 by MK801 and ketamine: implications for PCP derivative-induced disease models.Generation and customization of biosynthetic excitable tissues for electrophysiological studies and cell-based therapies.Computational Modeling of Electrophysiology and Pharmacotherapy of Atrial Fibrillation: Recent Advances and Future Challenges

P2860

Q28087459-3A4A0166-A265-45CE-AC5E-9F29AE8B6C1D Q28482100-49FD67F4-6FCF-4EEF-99AE-8896C5AB3E9F Q28540046-AFE3924A-3EA1-4A4D-9D22-028A3AA293B6 Q35129668-0D1E4DA8-14F7-4C65-992B-0666577F948A Q35132301-1B48174C-CA4D-438D-8BF5-245BE3744832 Q35489060-86F39D1F-3DB4-43CC-9F12-B2EE44E0C176 Q35650683-7842CCC0-7647-4585-8D2E-371A32BB03FF Q36009627-7848AB06-8D62-446C-AED1-F9BBE4499618 Q36013079-25B6E2FB-E454-48F7-9001-FD56CAD89FD2 Q36124154-356C062C-86F6-4A59-98CA-35AA541FBE24 Q36240239-31895B31-F423-4D1E-92A1-D9D359D95FA0 Q37418226-41FEE24C-AAB5-43DA-A54C-51882893198C Q37614642-8763D0B0-829A-4EDB-84AF-3FE813761FE4 Q37974077-0BE7F145-192B-4CA8-B60F-4CDA6D396CB0 Q37998312-28B26B30-307F-4FE8-B4D7-06839B2D37DA Q38062581-74E9761F-7B9D-4B79-8314-8E222D194CB1 Q38111636-69537A24-78EA-423E-83C4-458779CD340E Q38142991-E9B80E62-BDB7-47B9-9B0B-0CFBA8B0861D Q38194443-5DC99FD0-B623-4CE0-9D6D-A240380AE0A1 Q38201409-FB97E9AB-EEDB-4E40-930D-93F81B446B1F Q38643358-A4E74E8A-13B8-4110-BBCF-C116D53530BF Q38699661-07DBB4A6-A260-4E6B-90C8-5C84DABB0881 Q38950812-8FB2351B-ED60-446A-91DA-26DDB992FEF5 Q38960630-38249088-7F76-4B55-841D-042B7CB9D08A Q38972404-B66A1644-AB38-4C71-85D9-0C569C445B41 Q39760319-6BDFA70D-2FB4-43FC-8AFA-DCA2E300009D Q42226298-A3E70800-E745-4E17-B9A4-30ABF06A0B54 Q42694191-A0D469DF-78E8-4C0C-ACA2-8DC91EF1505D Q43105838-E03AE76D-0521-423B-A33B-621BD9C01775 Q43228224-82750EB5-E0BC-4FDF-A085-E1861EC22F68 Q43710067-513BCA7A-71C5-432A-A21E-D2743C16BC30 Q46270262-E4CC23FE-ED01-46CB-BEAA-18802299B969 Q47161197-2B239827-452A-46A4-9359-3E6A67D9DF1F Q47911098-0AD6E188-7EF2-4100-AD5A-A0AB8142DD24 Q48181488-D2697E48-4609-479E-A6AA-359AB0BA5924 Q48605283-8B24C57E-0D7C-430F-BC80-ED74B72AC8D4 Q51354497-9C651006-8E20-4F9E-B481-45D6FD28530D Q52560210-4C3396C0-059B-4B1D-ABF1-980E0AB68356 Q52603774-A910F1CC-3F94-4DAB-A462-69F059FDE380 Q57161239-7686F48C-0B69-42F3-ACB5-ACE6A457395C

P2860

Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications.

http://www.wikidata.org/entity/Q37821136

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 December 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications.

@en

Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications.

@nl

type

label

Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications.

@en

Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications.

@nl

prefLabel

Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications.

@en

Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications.

@nl

P1433

Q37821136-AAA6E10C-F8D5-4755-A73B-90A83CCC6F24

P1476

Q37821136-F67260FC-FD35-4622-8091-FF815195A712

P2093

Q37821136-DB070CC2-E90E-4663-BC1D-39CDCB32122C

Q37821136-E1D9E3B0-23A8-41B8-84CE-1FB1B7D2EBC5

P2860

Q37821136-01B8AC60-9183-4A96-8C91-91A65DC04FF9

Q37821136-01F4D903-EFD2-4DAC-859F-8B1B75DC8BD2

Q37821136-073E4401-762C-4E90-B2B3-15777FF5709D

Q37821136-0769FA23-D850-4D00-835C-08354B01C309

Q37821136-0A62426F-B675-4A92-B230-5B03560CA285

Q37821136-0AF82406-AF97-4A2D-BAFD-FCE2B2BA5E5E

Q37821136-10E7C74E-D76A-4B87-A5F4-8F89F1D18B97

Q37821136-167E7A73-88EC-40A1-A917-C405470282FC

Q37821136-17910EEB-F6EF-4BB2-9A93-B0A7A828169D

Q37821136-18B402F1-961B-48D5-9CED-CA79895A9860

P304

Q37821136-3D8B819C-FAF8-442B-A4ED-F99E1CEE8A78

P31

Q37821136-5e7260a3-ff83-4fa5-8971-e8152c19dbb7

Q37821136-96A02C42-24F6-4F87-8450-4E39CD75BF8E

P356

Q37821136-30646D5E-60A4-431B-B2A7-EF67274F1279

P433

Q37821136-C24B91AE-DB17-489D-9D38-40B1FB3475C6

P478

Q37821136-6EEEFEC7-64FF-43AD-8908-4CBC39A71B66

P50

Q37821136-e79fb362-40f1-c96b-e595-09c62254c4bf

P577

Q37821136-E2C49B9A-D8FF-487A-85CA-51F22E99DCB4

P5875

Q37821136-42D98CA1-8ADB-45C2-9271-50068B5CC4AE

P698

Q37821136-C175EEE2-8DCB-4DF8-A915-06BC3D304B51

P356

P1433

Cardiovascular Research

P1476

Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications.

@en

P2093

Erich Wettwer

http://www.w3.org/2001/XMLSchema#string

Ursula Ravens

http://www.w3.org/2001/XMLSchema#string

P2860

The Structure of the Potassium Channel: Molecular Basis of K+ Conduction and Selectivity

Modulation of the human Kv1.5 channel by protein kinase C activation: role of the Kvbeta1.2 subunit

A novel K+ channel beta-subunit (hKv beta 1.3) is produced via alternative mRNA splicing

Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation

Four and a half LIM protein 1: a partner for KCNA5 in human atrium

Functional differences in Kv1.5 currents expressed in mammalian cell lines are due to the presence of endogenous Kv beta 2.1 subunits

Localization of the Kv1.5 K+ channel protein in explanted cardiac tissue

Association of Src tyrosine kinase with a human potassium channel mediated by SH3 domain

Structure of the cytoplasmic beta subunit-T1 assembly of voltage-dependent K+ channels

SAP97 increases Kv1.5 currents through an indirect N-terminal mechanism

P304

776-785

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CVR/CVQ398

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49684762

http://www.w3.org/2001/XMLSchema#string

P698

21159668

http://www.w3.org/2001/XMLSchema#string